Purchase Order 75N95022P00357

Award Date 7/11/22
Potential Completion Date 7/10/23
Potential Value $553K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boulder, CO 80301, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $455,000 firm fixed price purchase order from the National Institutes of Health's National Institute on Aging to examine the cerebral spinal fluid (CSF) and plasma proteome in Alzheimer's and chronic kidney disease. Through its proprietary SomaScan platform, Somalogic will supply aptamer-based assays and associated laboratory testing capable of measuring thousands of proteins in small-volume...
This firm fixed-price purchase order valued at $1,098,000 was awarded by the National Institutes of Health National Institute on Aging to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The contract calls for utilization of an aptamer-based proteomics platform to analyze approximately 1,800 archived plasma samples from the Baltimore Longitudinal Study of Aging. The purpose is to identify molecular pathways that accelerate pathological phosphorylation of tau, which is...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm-fixed-price purchase order valued at $26,000 to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. to perform discovery-based proteomic assays on approximately 40 human plasma samples. The work will be performed in Boulder, Colorado over a period of six months from August 2023 through March 2024. The purpose of the assays is to identify proteomic markers of...
Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $25,000 purchase order contract by the National Institutes of Health's National Institute on Aging to provide laboratory testing services for SOMASCAN discovery. The testing services will support the NIH/NIA's biomedical research efforts over a one-year period of performance in Boulder, Colorado. As the prime contractor, CM Life Sciences II Inc. will leverage its proteomics platform to analyze...
The National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, awarded a $24,975.00 firm-fixed-price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The contract is for laboratory testing services using Somalogic's proprietary SomaScan Discovery V4.1 platform, which can measure 7,000 protein biomarkers from plasma samples. This contract supports the agency's research initiatives and does not have a set-aside...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $566,800 firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The contract calls for the delivery of an aptamer-based proteomic assay to measure approximately 7,000 proteins in approximately 872 human plasma samples from the Nutrition for Precision Health cohort. The assay results will identify proteomic signatures that predict...
This is a firm-fixed-price purchase order awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. The $24,975.00 contract is for laboratory support services to deliver 7,000 protein measurements from plasma samples using Somalogic's proprietary SomaScan Discovery V4.1 platform. The services are to be performed at Somalogic's facility in Boulder, Colorado, and...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $28,000 purchase order contract to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. for whole-cell proteome analysis services. The contract is a firm fixed price order for proteome analysis to be performed at the contractor's Potomac, Maryland facility between August 9, 2023 and December 31, 2023 to support the NIH National Institute on Aging's research...
This firm-fixed-price purchase order was awarded by the National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The $152,200.00 contract is for the purchase and installation of SomaScan 7K protein biomarker assay kits and reagents. This work supports ongoing and developing proteomics research projects within the NIA's Translational Gerontology Branch and other laboratories, including...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $2.1 million firm fixed-price purchase order to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. The contract calls for the delivery of 53 SomaScan 7K kits to be used for proteomics analysis of human samples at the National Institutes of Health National Institute on Drug Abuse. The solicitation sought qualified vendors to supply the kits, which must be capable...

Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $552,500 firm fixed price purchase order by the National Institutes of Health National Institute on Aging to perform discovery-based proteomic assays on approximately 850 human plasma samples. The purpose is to identify molecular pathways that accelerate cognitive decline across stages of Alzheimer's disease, as requested in the solicitation titled "Predicting cognitive decline across the Alzheimer's disease spectrum using plasma proteomics." Work will be conducted over a one-year period of performance ending July 2023 in Boulder, Colorado, with no subcontractors or set-aside designation indicated. This contract supports the National Institute on Aging's efforts to better understand Alzheimer's disease progression and identify potential targets for new diagnostics and treatments.

Generated 12/29/23, 4:52 PM